- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
54
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
54 companies
Almirall
Market Cap: €2.3b
Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
ALM
€10.76
7D
1.1%
1Y
14.7%
Galderma Group
Market Cap: CHF 27.8b
Operates as a dermatology company worldwide.
GALD
CHF 117.30
7D
2.0%
1Y
60.7%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.9b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€56.20
7D
2.6%
1Y
-33.7%
Phibro Animal Health
Market Cap: US$1.1b
Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.
PAHC
US$28.00
7D
9.6%
1Y
59.8%
SK Biopharmaceuticals
Market Cap: ₩7.2t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩92,400.00
7D
0.4%
1Y
15.6%
Suzhou Zelgen BiopharmaceuticalsLtd
Market Cap: CN¥30.6b
Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
688266
CN¥115.20
7D
7.2%
1Y
121.7%
Tonghua Dongbao Pharmaceutical
Market Cap: CN¥15.7b
Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.
600867
CN¥8.08
7D
-1.5%
1Y
0.2%
RemeGen
Market Cap: HK$41.3b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$64.50
7D
18.5%
1Y
267.3%
Medy-Tox
Market Cap: ₩1.2t
Operates as a biopharmaceutical company in South Korea.
A086900
₩171,500.00
7D
-3.6%
1Y
9.0%
Bonesupport Holding
Market Cap: SEK 19.0b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 289.20
7D
3.3%
1Y
1.5%
Vertex Pharmaceuticals
Market Cap: US$118.0b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$459.62
7D
3.2%
1Y
-4.6%
BioLife Solutions
Market Cap: US$1.1b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$22.84
7D
6.0%
1Y
11.7%
GC Biopharma
Market Cap: ₩1.5t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩130,400.00
7D
3.2%
1Y
10.4%
Hypera
Market Cap: R$17.5b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$27.70
7D
1.9%
1Y
-3.6%
AstraZeneca
Market Cap: UK£160.3b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£103.36
7D
2.1%
1Y
-14.2%
Simcere Pharmaceutical Group
Market Cap: HK$27.3b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$10.58
7D
-4.9%
1Y
91.3%
Repligen
Market Cap: US$7.2b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$127.47
7D
2.5%
1Y
6.4%
Everest Medicines
Market Cap: HK$21.8b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$67.10
7D
7.9%
1Y
265.5%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥13.1b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥18.98
7D
12.6%
1Y
21.8%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €191.9m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€7.84
7D
-3.2%
1Y
-15.9%
Orchid Pharma
Market Cap: ₹38.3b
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
ORCHPHARMA
₹739.05
7D
3.5%
1Y
-36.8%
Eli Lilly
Market Cap: US$700.8b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$780.67
7D
0.1%
1Y
-15.0%
ArcticZymes Technologies
Market Cap: NOK 868.2m
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally.
AZT
NOK 17.00
7D
2.4%
1Y
-27.5%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$82.7b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$352.40
7D
7.7%
1Y
139.7%
Hugel
Market Cap: ₩3.7t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩362,000.00
7D
-1.9%
1Y
59.5%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥42.6b
Shanghai Allist Pharmaceuticals Co., Ltd.
688578
CN¥92.24
7D
-0.9%
1Y
49.6%
Genscript Biotech
Market Cap: HK$32.9b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$14.64
7D
-1.1%
1Y
65.6%
Solara Active Pharma Sciences
Market Cap: ₹30.7b
Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.
SOLARA
₹632.50
7D
-0.7%
1Y
4.3%
Innovent Biologics
Market Cap: HK$147.4b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$82.55
7D
5.3%
1Y
118.4%
High Tide
Market Cap: CA$251.2m
Engages in the cannabis retail business in Canada.
HITI
CA$3.10
7D
-1.3%
1Y
11.5%
BioGaia
Market Cap: SEK 10.8b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 106.50
7D
0.3%
1Y
-15.4%
AcrobiosystemsLtd
Market Cap: CN¥8.5b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
301080
CN¥68.12
7D
-4.8%
1Y
109.9%
Egyptian International Pharmaceutical Industries
Market Cap: ج.م7.6b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م50.91
7D
0.5%
1Y
29.4%
Sawai Group Holdings
Market Cap: JP¥209.2b
Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.
4887
JP¥1,803.00
7D
-1.6%
1Y
-17.4%
IBN SINA Pharmaceutical Industry
Market Cap: ৳9.0b
Produces and sells pharmaceutical drugs in Bangladesh and internationally.
IBNSINA
৳288.90
7D
-1.8%
1Y
16.7%
Navamedic
Market Cap: NOK 395.6m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 22.40
7D
-2.6%
1Y
-33.1%